clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with clarithromycin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Sander P et al. | Ribosomal drug resistance in mycobacteria. | 1996 Jan-Feb | Res. Microbiol. | pmid:8761724 |
Yatera K et al. | The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases. | 2017 | Respir Investig | pmid:29153420 |
Higashi F et al. | Additional treatment with clarithromycin reduces fever duration in patients with influenza. | 2014 | Respir Investig | pmid:25169846 |
Suzuki K et al. | Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance. | 2018 | Respir Investig | pmid:29325687 |
Kadota J et al. | Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. | 2003 | Respir Med | pmid:12854636 |
Miravitlles M et al. | Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. | 2005 | Respir Med | pmid:15950136 |
Lode H et al. | Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia. | 2003 | Respir Med | pmid:14561021 |
Niederman MS et al. | Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents. | 2006 | Respir Med | pmid:16531032 |
Hoeffken G et al. | The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia. | 2001 | Respir Med | pmid:11453311 |
Hagberg L et al. | Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis. | 2003 | Respir Med | pmid:12814146 |
Kohyama T et al. | Clarithromycin inhibits fibroblast migration. | 2008 | Respir Med | pmid:18701271 |
Abe M et al. | A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D4/E4 receptor antagonist. | 1998 | Respir Med | pmid:9893782 |
Kobashi Y et al. | A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. | 2007 | Respir Med | pmid:16750618 |
Simoens S et al. | Preventing COPD exacerbations with macrolides: a review and budget impact analysis. | 2013 | Respir Med | pmid:23352223 |
Banerjee D et al. | The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD. | 2005 | Respir Med | pmid:15715188 |
Carbon C et al. | Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia. | 2006 | Respir Med | pmid:16376537 |
Persson CG and Uller L | Resolution of cell-mediated airways diseases. | 2010 | Respir. Res. | pmid:20540713 |
Ballard HO et al. | Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. | 2007 | Respir. Res. | pmid:17550598 |
Amado-RodrÃguez L et al. | Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury. | 2013 | Respir. Res. | pmid:23663489 |
Beigelman A et al. | Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis. | 2010 | Respir. Res. | pmid:20591166 |
du Toit LC et al. | Tuberculosis chemotherapy: current drug delivery approaches. | 2006 | Respir. Res. | pmid:16984627 |
Komiya K et al. | Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts. | 2017 | Respir. Res. | pmid:28219384 |
Legssyer R et al. | Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. | 2006 | Respir. Res. | pmid:17064416 |
Liapakis IE et al. | Penetration of clarithromycin in experimental pleural empyema model fluid. | 2005 May-Jun | Respiration | pmid:15942299 |
Rovira E et al. | Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime. | 1999 | Respiration | pmid:10516537 |
Huchon G | How to manage the low-risk patient with lower respiratory tract infection? | 1999 | Respiration | pmid:10577170 |
Kobashi Y and Matsushima T | The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study. | 2007 | Respiration | pmid:16954651 |
Jouneau S et al. | Clarithromycin stops lung function decline in airway-centered interstitial fibrosis. | 2013 | Respiration | pmid:23095475 |
Fujiuchi S et al. | Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease. | 2003 Jan-Feb | Respiration | pmid:12584395 |
Soepandi P et al. | The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections. | 1998 | Respirology | pmid:9692520 |
Ruiz-González A et al. | Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. | 2007 | Respirology | pmid:17207036 |
Ding FM et al. | Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection. | 2012 | Respirology | pmid:22404374 |
Strouvalis I et al. | Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence. | 2018 | Respirology | pmid:29741298 |
Kobashi Y et al. | Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease. | 2006 | Respirology | pmid:17052313 |
Sawabuchi T et al. | Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza. | 2009 | Respirology | pmid:19909463 |
Okimoto N et al. | Clinical features of Q fever pneumonia. | 2004 | Respirology | pmid:15182283 |
Kikuchi E et al. | Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid. | 2008 | Respirology | pmid:18339019 |
Isozumi R et al. | Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae. | 2009 | Respirology | pmid:19732389 |
Matieli LC et al. | Mycobacterium abscessus endophthalmitis: treatment dilemma and review of the literature. | 2006 | Retina (Philadelphia, Pa.) | pmid:16963860 |
Unal M et al. | Ocular toxicity of intravitreal clarithromycin. | 1999 | Retina (Philadelphia, Pa.) | pmid:10546942 |
MorfÃn Maciel BM and Castillo Ramos HA | [Reactive polyarthritis and painful dermatographism caused by Helicobacter pylori]. | 2002 May-Jun | Rev Alerg Mex | pmid:12190006 |
Cofré Guerra J | [Pertussis chemoprophylaxis: a sterile effort?]. | 2006 | Rev Chilena Infectol | pmid:16462967 |
Olmos MartÃnez JM et al. | [Definitive treatment of Helicobacter pylori infection in MALT low degree gastric lymphoma]. | 2003 | Rev Clin Esp | pmid:14622518 |
Alba D et al. | [Clarithromycin in the treatment of cerebral toxoplasmosis associated with HIV infection]. | 1993 | Rev Clin Esp | pmid:8516514 |
DÃaz F et al. | [Cat-scratch disease. A report of 4 cases and a review of the literature]. | 1997 | Rev Clin Esp | pmid:9102668 |
Baena DÃez JM et al. | [Are 5 days of omeprazole plus 2 antibiotics enough for eradication of H. pylori? Comments on sample size]. | 1999 | Rev Clin Esp | pmid:10432821 |
Gisbert JP et al. | [Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?]. | 1998 | Rev Clin Esp | pmid:9844453 |
Gisbert JP et al. | [Role of pantoprazole in the eradicating treatment of Helicobacter pylori]. | 1998 | Rev Clin Esp | pmid:9844458 |
Asencio Marchante R and Lissen Otero E | [Secondary prevention of opportunistic infections in HIV-infected patients]. | 2001 | Rev Clin Esp | pmid:11345612 |
Murcia J et al. | [Acute myocardial failure in a young man: Q-fever myocarditis]. | 2002 | Rev Esp Cardiol | pmid:12199986 |
Vallejo Camazón N et al. | [Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection]. | 2002 | Rev Esp Cardiol | pmid:12199987 |
Garza González E et al. | [Helicobacter pylori erradication and its relation to antibiotic resistance and CYP2C19 status]. | 2007 | Rev Esp Enferm Dig | pmid:17417917 |
de Artaza Varasa T et al. | [Effect of Helicobacter pylori eradication on patients with functional dyspepsia]. | 2008 | Rev Esp Enferm Dig | pmid:19025303 |
Gisbert JP et al. | [What is the current role of clarithromycin in the eradication of Helicobacter pylori?]. | 1997 | Rev Esp Enferm Dig | pmid:9221019 |
Rodrigo Sáez L et al. | [The efficacy of using a short course of 6-day duration (OCA-6) in the treatment to eradicate Helicobacter pylori infection. Omeprazole, clarithromycin, amoxicillin]. | 1997 | Rev Esp Enferm Dig | pmid:9115827 |
Sainz R et al. | [Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. | 1999 | Rev Esp Enferm Dig | pmid:10601771 |
Rojas Feria M et al. | Resistance of Helicobacter pylori to antimicrobial treatment in a Seville hospital catchment area. | 2000 | Rev Esp Enferm Dig | pmid:11468787 |
RodrÃguez Téllez M et al. | Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection. | 1999 | Rev Esp Enferm Dig | pmid:10491487 |
Gisbert JP | [Lansoprazole: a review of its role in Helicobacter pylori eradication therapy]. | 1999 | Rev Esp Enferm Dig | pmid:10231305 |
González Carro P et al. | [Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori]. | 1998 | Rev Esp Enferm Dig | pmid:9780793 |
Boixeda D et al. | Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success. | 2003 | Rev Esp Enferm Dig | pmid:12760710 |
Gisbert JP et al. | Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment. | 2003 | Rev Esp Enferm Dig | pmid:12760719 |
Torres-Debat ME et al. | Antimicrobial susceptibility of Helicobacter pylori and mechanisms of clarithromycin resistance in strains isolated from patients in Uruguay. | 2009 | Rev Esp Enferm Dig | pmid:20001152 |
Boixeda de Miquel D | [Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer]. | 1997 | Rev Esp Enferm Dig | pmid:9494374 |
Pérez Mota A et al. | Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules. | 1997 | Rev Esp Enferm Dig | pmid:9494375 |
Castro-Fernández M et al. | Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori. | 2009 | Rev Esp Enferm Dig | pmid:19630462 |
Fernández Martos R et al. | Acute psychotic episode secondary to Helicobacter pylori eradication treatment. | 2017 | Rev Esp Enferm Dig | pmid:28071063 |
Carabias ML et al. | [Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study]. | 2001 | Rev Esp Quimioter | pmid:11704772 |
Gordillo RM et al. | [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)]. | 2003 | Rev Esp Quimioter | pmid:12750758 |
Cantón E et al. | [In vitro susceptibility to antibiotics and the most common Streptococcus pneumoniae serotypes: a multicenter study]. | 2005 | Rev Esp Quimioter | pmid:15915232 |
Agudo S et al. | Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism. | 2011 | Rev Esp Quimioter | pmid:21412667 |
DÃaz-Reganon J et al. | [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors]. | 2006 | Rev Esp Quimioter | pmid:16688289 |
Agudo S et al. | [High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children]. | 2009 | Rev Esp Quimioter | pmid:19544100 |
Orellana MA and Gómez-Lus ML | [Which is the best empirical treatment in patients with urethritis?]. | 2011 | Rev Esp Quimioter | pmid:21947096 |
Vega AE et al. | [Detection of resistance to clarithromycin in clinical isolates of Helicobacter pylori from children and adults]. | 2003 | Rev Esp Quimioter | pmid:12750757 |
Ruiz-Aragón J et al. | [Susceptibility to antimicrobial agents of rapidly growing mycobacteria]. | 2007 | Rev Esp Quimioter | pmid:18563216 |
Guirao-Arrabal E et al. | Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci. | 2016 | Rev Esp Quimioter | pmid:26888341 |
Miglietta F et al. | A rare case of Saprochaete capitata fungemia in a critical ill patient without hematologic and oncological disorders. | 2016 | Rev Esp Quimioter | pmid:26785226 |
Gálvez-Múgica MA et al. | [Meta-analysis of clarithromycin compared to other antibiotics for the treatment of lower respiratory tract infections]. | 2003 | Rev Esp Quimioter | pmid:14961134 |
Alarcón T et al. | [In vitro activity of clarithromycin and metronidazole against Helicobacter pylori in different incubation atmospheres]. | 2002 | Rev Esp Quimioter | pmid:12587039 |
Rubio-Terrés C et al. | [Pharmacoeconomic analysis of community-acquired pneumonia treatment with telithromycin or clarithromycin]. | 2003 | Rev Esp Quimioter | pmid:14702121 |
Abad-Santos F et al. | [Meta-analysis of clarithromycin compared with other antimicrobial drugs in the treatment of upper respiratory tract infections]. | 2003 | Rev Esp Quimioter | pmid:14702124 |
Alarcón T et al. | [In vitro activity of furazolidone and nitrofurantoin in Helicobacter pylori clinical isolates and study of mutation rate]. | 2005 | Rev Esp Quimioter | pmid:16446791 |
Abasolo Osinaga E et al. | [Dispensation and cost of antimicrobials in Spain (1998-2000)]. | 2005 | Rev Esp Quimioter | pmid:16446789 |
Orden MartÃnez B et al. | [Haemophilus spp. antimicrobial susceptibility in Health Area 6 in Madrid, Spain (2000-2004)]. | 2005 | Rev Esp Quimioter | pmid:16130040 |
Vakil N | Helicobacter pylori treatment: is sequential or quadruple therapy the answer? | 2008 | Rev Gastroenterol Disord | pmid:18641590 |
Guarner J and Mohar A | [The association between Helicobacter pylori and gastric neoplasia. Epidemiologic evidence]. | 2000 Oct-Dec | Rev Gastroenterol Mex | pmid:11464618 |
Ladrón de Guevara L et al. | [Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment]. | 2004 Oct-Dec | Rev Gastroenterol Mex | pmid:15765971 |
Dehesa M et al. | [Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer]. | 1998 Apr-Jun | Rev Gastroenterol Mex | pmid:10068730 |
RamÃrez Ramos A | [Treatment of Helicobacter pylori infection: current status]. | 1995 | Rev Gastroenterol Peru | pmid:8520021 |
RodrÃguez W et al. | [Omeprazole, amoxicillin and clarithromycin in the treatment of helicobacterpylori, in 7 and 10-day regimens]. | 2003 Jul-Sep | Rev Gastroenterol Peru | pmid:14532918 |
Velasco BenÃtez CA and Amorocho Pérez RD | [Treatment of gastritis-associated Helicobacter pylori infection in children]. | 2002 Apr-Jun | Rev Gastroenterol Peru | pmid:12098744 |
Silva FM et al. | Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer. | 2001 Jan-Feb | Rev Hosp Clin Fac Med Sao Paulo | pmid:11378678 |
Pinto LA et al. | Effect of clarithromycin on the cell profile of bronchoalveolar lavage fluid in mice with neutrophil-predominant lung disease. | 2004 | Rev Hosp Clin Fac Med Sao Paulo | pmid:15286828 |
Souza R et al. | Diffuse panbronchiolitis: an underdiagnosed disease? Study of 4 cases in Brazil. | 2002 Jul-Aug | Rev Hosp Clin Fac Med Sao Paulo | pmid:12244337 |
[Zeclar, a new antibiotic (clarithromycin 250 mg from Abbott laboratories]. | 1994 | Rev Infirm | pmid:7652424 | |
Camara B et al. | [Infection due to Mycobacterium malmoense in an immunocompetent patient]. | 2008 | Rev Mal Respir | pmid:19106910 |
Dixmier A et al. | [Pulmonary infections with Mycobacterium xenopi in patients without HIV infection]. | 2007 | Rev Mal Respir | pmid:17417167 |
Frija-Masson J et al. | [Non-tuberculous mycobacterial infection of a totally implanted perfusion device]. | 2015 | Rev Mal Respir | pmid:25480387 |
Payen MC et al. | [Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection]. | 1997 | Rev Mal Respir | pmid:9496599 |